Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: MULTIPLE SCLEROSIS, . Treffer: 328

2019

Bridel, C; van Wieringen, WN; Zetterberg, H; Tijms, BM; Teunissen, CE; and the NFL Group; Alvarez-Cermeño, JC; Andreasson, U; Axelsson, M; Bäckström, DC; Bartos, A; Bjerke, M; Blennow, K; Boxer, A; Brundin, L; Burman, J; Christensen, T; Fialová, L; Forsgren, L; Frederiksen, JL; Gisslén, M; Gray, E; Gunnarsson, M; Hall, S; Hansson, O; Herbert, MK; Jakobsson, J; Jessen-Krut, J; Janelidze, S; Johannsson, G; Jonsson, M; Kappos, L; Khademi, M; Khalil, M; Kuhle, J; Landén, M; Leinonen, V; Logroscino, G; Lu, CH; Lycke, J; Magdalinou, NK; Malaspina, A; Mattsson, N; Meeter, LH; Mehta, SR; Modvig, S; Olsson, T; Paterson, RW; Pérez-Santiago, J; Piehl, F; Pijnenburg, YAL; Pyykkö, OT; Ragnarsson, O; Rojas, JC; Romme Christensen, J; Sandberg, L; Scherling, CS; Schott, JM; Sellebjerg, FT; Simone, IL; Skillbäck, T; Stilund, M; Sundström, P; Svenningsson, A; Tortelli, R; Tortorella, C; Trentini, A; Troiano, M; Turner, MR; van Swieten, JC; Vågberg, M; Verbeek, MM; Villar, LM; Visser, PJ; Wallin, A; Weiss, A; Wikkelsø, C; Wild, EJ Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
JAMA Neurol. 2019; [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Chatterjee, M; Koel-Simmelink, MJ; Verberk, IM; Killestein, J; Vrenken, H; Enzinger, C; Ropele, S; Fazekas, F; Khalil, M; Teunissen, CE Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis.
Mult Scler J Exp Transl Clin. 2019; 4(4):2055217318819535-2055217318819535 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

d'Ambrosio, A; Valsasina, P; Gallo, A; De Stefano, N; Pareto, D; Barkhof, F; Ciccarelli, O; Enzinger, C; Tedeschi, G; Stromillo, ML; Arévalo, MJ; Hulst, HE; Muhlert, N; Koini, M; Filippi, M; Rocca, MA Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis.
Mult Scler. 2019; 1352458519837707-1352458519837707
PubMed FullText FullText_MUG

 

Filippi, M; Brück, W; Chard, D; Fazekas, F; Geurts, JJG; Enzinger, C; Hametner, S; Kuhlmann, T; Preziosa, P; Rovira, À; Schmierer, K; Stadelmann, C; Rocca, MA; Attendees of the Correlation between Pathological and MRI findings in MS workshop Association between pathological and MRI findings in multiple sclerosis.
LANCET NEUROL. 2019; 18(2): 198-210.
Web of Science PubMed FullText FullText_MUG

 

Gasperini, C; Prosperini, L; Tintoré, M; Sormani, MP; Filippi, M; Rio, J; Palace, J; Rocca, MA; Ciccarelli, O; Barkhof, F; Sastre-Garriga, J; Vrenken, H; Frederiksen, JL; Yousry, TA; Enzinger, C; Rovira, A; Kappos, L; Pozzilli, C; Montalban, X; De Stefano, N; and the MAGNIMS Study Group Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.
Neurology. 2019; 92(4):180-192 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Guger, M; Enzinger, C; Leutmezer, F; Kraus, J; Kalcher, S; Kvas, E; Berger, T; Austrian MS Treatment Registry (AMSTR) Real-life use of oral disease-modifying treatments in Austria.
Acta Neurol Scand. 2019; 140(1):32-39
Web of Science PubMed FullText FullText_MUG

 

Hagens, MHJ; Burggraaff, J; Kilsdonk, ID; Ruggieri, S; Collorone, S; Cortese, R; Cawley, N; Sbardella, E; Andelova, M; Amann, M; Lieb, JM; Pantano, P; Lissenberg-Witte, BI; Killestein, J; Oreja-Guevara, C; Wuerfel, J; Ciccarelli, O; Gasperini, C; Lukas, C; Rovira, A; Barkhof, F; Wattjes, MP; Yousry, T; De Stefano, N; Enzinger, C; Filippi, M; Rocca, MA; Frederiksen, JL; Kappos, L; Palace, J; Sastre-Garriga, J; Vrenken, H Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study
MULT SCLER J. 2019; 25(3): 352-360. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Haindl, MT; Köck, U; Zeitelhofer-Adzemovic, M; Fazekas, F; Hochmeister, S The formation of a glial scar does not prohibit remyelination in an animal model of multiple sclerosis.
Glia. 2019; 67(3):467-481 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

International Multiple Sclerosis Genetics Consortium A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis.
Nat Commun. 2019; 10(1): 2236-2236. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Jensen, PEH; Warnke, C; Ingenhoven, K; Piccoli, L; Gasis, M; Hermanrud, C; Fernandez-Rodriguez, BM; Ryner, M; Kramer, D; Link, J; Ramanujam, R; Auer, M; Buck, D; Grummel, V; Bertotti, E; Fissolo, N; Oliver-Martos, B; Nytrova, P; Khalil, M; Guger, M; Rathmaier, S; Sievers-Stober, C; Lindberg, RLP; Hässler, S; Bachelet, D; Aktas, O; Donnellan, N; Lawton, A; Hemmer, B; Havrdova, EK; Kieseier, B; Hartung, HP; Comabella, M; Montalban, X; Derfuss, T; Sellebjerg, F; Dönnes, P; Pallardy, M; Spindeldreher, S; Broët, P; Deisenhammer, F; Fogdell-Hahn, A; Sorensen, PS; ABIRISK Consortium Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study.
J Neuroimmunol. 2019; 326:19-27
Web of Science PubMed FullText FullText_MUG

 

Kor, D; Birkl, C; Ropele, S; Doucette, J; Xu, T; Wiggermann, V; Hernández-Torres, E; Hametner, S; Rauscher, A The role of iron and myelin in orientation dependent R2* of white matter.
NMR Biomed. 2019; 32(7):e4092-e4092
Web of Science PubMed FullText FullText_MUG

 

Leurs, CE; Twaalfhoven, H; Lissenberg-Witte, BI; van Pesch, V; Dujmovic, I; Drulovic, J; Castellazzi, M; Bellini, T; Pugliatti, M; Kuhle, J; Villar, LM; Alvarez-Cermeño, JC; Alvarez-Lafuente, R; Hegen, H; Deisenhammer, F; Walchhofer, LM; Thouvenot, E; Comabella, M; Montalban, X; Vécsei, L; Rajda, C; Galimberti, D; Scarpini, E; Altintas, A; Rejdak, K; Frederiksen, JL; Pihl-Jensen, G; Jensen, P; Khalil, M; Voortman, MM; Fazekas, F; Saiz, A; La Puma, D; Vercammen, M; Vanopdenbosch, L; Uitdehaag, B; Killestein, J; Bridel, C; Teunissen, C Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
Mult Scler. 2019; 224(6):1352458519845844-1352458519845844
PubMed FullText FullText_MUG

 

Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fuchs, S; Bachmaier, G; Enzinger, C; Fazekas, F The impact of vascular risk factors on brain volume and lesion load in patients with early multiple sclerosis
MULT SCLER J. 2019; 25(1): 48-54.
Web of Science PubMed FullText FullText_MUG

 

Santangelo, G; Altieri, M; Enzinger, C; Gallo, A; Trojano, L Cognitive reserve and neuropsychological performance in multiple sclerosis: A meta-analysis.
Neuropsychology. 2019; 33(3):379-390
Web of Science PubMed FullText FullText_MUG

 

2018

Amiri, H; de Sitter, A; Bendfeldt, K; Battaglini, M; Gandini Wheeler-Kingshott, CAM; Calabrese, M; Geurts, JJG; Rocca, MA; Sastre-Garriga, J; Enzinger, C; de Stefano, N; Filippi, M; Rovira, Á; Barkhof, F; Vrenken, H; MAGNIMS Study Group Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.
NEUROIMAGE-CLIN. 2018; 19(3): 466-475. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Berger, T; Adamczyk-Sowa, M; Csepany, T; Fazekas, F; Fabjan, TH; Horakova, D; Illes, Z; Klimova, E; Leutmezer, F; Rejdak, K; Rozsa, C; Jazbec, SS; Szilasiova, J; Turcani, P; Vachova, M; Vecsei, L; Havrdova, E Management of multiple sclerosis patients in central European countries: current needs and potential solutions
THER ADV NEUROL DISO. 2018; 11: [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Birkl, C; Carassiti, D; Hussain, F; Langkammer, C; Enzinger, C; Fazekas, F; Schmierer, K; Ropele, S Assessment of ferritin content in multiple sclerosis brains using temperature-induced R*2 changes.
Magn Reson Med. 2018; 79(3):1609-1615 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

De Stefano, N; Giorgio, A; Tintoré, M; Pia Amato, M; Kappos, L; Palace, J; Yousry, T; Rocca, MA; Ciccarelli, O; Enzinger, C; Frederiksen, J; Filippi, M; Vrenken, H; Rovira, À; MAGNIMS study group Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.
Mult Scler. 2018; 24(2):214-221
Web of Science PubMed FullText FullText_MUG

 

Eshaghi, A; Marinescu, RV; Young, AL; Firth, NC; Prados, F; Jorge Cardoso, M; Tur, C; De Angelis, F; Cawley, N; Brownlee, WJ; De Stefano, N; Laura Stromillo, M; Battaglini, M; Ruggieri, S; Gasperini, C; Filippi, M; Rocca, MA; Rovira, A; Sastre-Garriga, J; Geurts, JJG; Vrenken, H; Wottschel, V; Leurs, CE; Uitdehaag, B; Pirpamer, L; Enzinger, C; Ourselin, S; Gandini Wheeler-Kingshott, CA; Chard, D; Thompson, AJ; Barkhof, F; Alexander, DC; Ciccarelli, O Progression of regional grey matter atrophy in multiple sclerosis.
Brain. 2018; 141(6):1665-1677 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Eshaghi, A; Prados, F; Brownlee, WJ; Altmann, DR; Tur, C; Cardoso, MJ; De Angelis, F; van de Pavert, SH; Cawley, N; De Stefano, N; Stromillo, ML; Battaglini, M; Ruggieri, S; Gasperini, C; Filippi, M; Rocca, MA; Rovira, A; Sastre-Garriga, J; Vrenken, H; Leurs, CE; Killestein, J; Pirpamer, L; Enzinger, C; Ourselin, S; Wheeler-Kingshott, CAMG; Chard, D; Thompson, AJ; Alexander, DC; Barkhof, F; Ciccarelli, O; MAGNIMS study group Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Ann Neurol. 2018; 83(2):210-222 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fabian, E; Schiller, D; Toplak, H; Brunner-Krainz, M; Fazekas, F; Schoefl, R; Krejs, GJ Clinical-Pathological Conference Series from the Medical University of Graz : Case No 153: A 55-year-old woman with atypical multiple sclerosis and irritable bowel syndrome.
Wien Klin Wochenschr. 2018; 130(3-4):151-160 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Filippi, M; Preziosa, P; Meani, A; Ciccarelli, O; Mesaros, S; Rovira, A; Frederiksen, J; Enzinger, C; Barkhof, F; Gasperini, C; Brownlee, W; Drulovic, J; Montalban, X; Cramer, SP; Pichler, A; Hagens, M; Ruggieri, S; Martinelli, V; Miszkiel, K; Tintore, M; Comi, G; Dekker, I; Uitdehaag, B; Dujmovic-Basuroski, I; Rocca, MA Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study
LANCET NEUROL. 2018; 17(2): 133-142.
Web of Science PubMed FullText FullText_MUG

 

Fissolo, N; Cervera-Carles, L; Villar Guimerans, LM; Lleó, A; Clarimón, J; Drulovic, J; Dujmovic, I; Voortman, M; Khalil, M; Gil, E; Navarro, L; Álvarez-Cermeño, JC; Montalban, X; Comabella, M Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.
Mult Scler. 2018; 1352458518786055-1352458518786055
PubMed FullText FullText_MUG

 

Geraldes, R; Ciccarelli, O; Barkhof, F; De Stefano, N; Enzinger, C; Filippi, M; Hofer, M; Paul, F; Preziosa, P; Rovira, A; DeLuca, GC; Kappos, L; Yousry, T; Fazekas, F; Frederiksen, J; Gasperini, C; Sastre-Garriga, J; Evangelou, N; Palace, J; MAGNIMS study group The current role of MRI in differentiating multiple sclerosis from its imaging mimics.
NAT REV NEUROL. 2018; 14(4): 199-213.
Web of Science PubMed FullText FullText_MUG

 

Guger, M; Enzinger, C; Leutmezer, F; Kraus, J; Kalcher, S; Kvas, E; Berger, T Real-life clinical use of natalizumab and fingolimod in Austria.
Acta Neurol Scand. 2018; 137(2):181-187
Web of Science PubMed FullText FullText_MUG

 

Khalil, M; Teunissen, CE; Otto, M; Piehl, F; Sormani, MP; Gattringer, T; Barro, C; Kappos, L; Comabella, M; Fazekas, F; Petzold, A; Blennow, K; Zetterberg, H; Kuhle, J Neurofilaments as biomarkers in neurological disorders.
Nat Rev Neurol. 2018; 14(10):577-589
Web of Science PubMed FullText FullText_MUG

 

Lex, H; Weisenbach, S; Sloane, J; Syed, S; Rasky, E; Freidl, W Social-emotional aspects of quality of life in multiple sclerosis.
Psychol Health Med. 2018; 23(4): 411-423.
Web of Science PubMed FullText FullText_MUG

 

Montalban, X; Gold, R; Thompson, AJ; Otero-Romero, S; Amato, MP; Chandraratna, D; Clanet, M; Comi, G; Derfuss, T; Fazekas, F; Hartung, HP; Havrdova, E; Hemmer, B; Kappos, L; Liblau, R; Lubetzki, C; Marcus, E; Miller, DH; Olsson, T; Pilling, S; Selmaj, K; Siva, A; Sorensen, PS; Sormani, MP; Thalheim, C; Wiendl, H; Zipp, F ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.
EUR J NEUROL. 2018; 25(2): 215-237.
Web of Science PubMed FullText FullText_MUG

 

Montalban, X; Gold, R; Thompson, AJ; Otero-Romero, S; Amato, MP; Chandraratna, D; Clanet, M; Comi, G; Derfuss, T; Fazekas, F; Hartung, HP; Havrdova, E; Hemmer, B; Kappos, L; Liblau, R; Lubetzki, C; Marcus, E; Miller, DH; Olsson, T; Pilling, S; Selmaj, K; Siva, A; Sorensen, PS; Sormani, MP; Thalheim, C; Wiendl, H; Zipp, F ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.
MULT SCLER J. 2018; 24(2): 96-120.
Web of Science PubMed FullText FullText_MUG

 

Parmar, K; Stadelmann, C; Rocca, MA; Langdon, D; D'Angelo, E; D'Souza, M; Burggraaff, J; Wegner, C; Sastre-Garriga, J; Barrantes-Freer, A; Dorn, J; Uitdehaag, BMJ; Montalban, X; Wuerfel, J; Enzinger, C; Rovira, A; Tintore, M; Filippi, M; Kappos, L; Sprenger, T; MAGNIMS study group The role of the cerebellum in multiple sclerosis-150 years after Charcot.
Neurosci Biobehav Rev. 2018; 89: 85-98.
Web of Science PubMed FullText FullText_MUG

 

Ryu, JK; Rafalski, VA; Meyer-Franke, A; Adams, RA; Poda, SB; Rios Coronado, PE; Pedersen, LØ; Menon, V; Baeten, KM; Sikorski, SL; Bedard, C; Hanspers, K; Bardehle, S; Mendiola, AS; Davalos, D; Machado, MR; Chan, JP; Plastira, I; Petersen, MA; Pfaff, SJ; Ang, KK; Hallenbeck, KK; Syme, C; Hakozaki, H; Ellisman, MH; Swanson, RA; Zamvil, SS; Arkin, MR; Zorn, SH; Pico, AR; Mucke, L; Freedman, SB; Stavenhagen, JB; Nelson, RB; Akassoglou, K Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration.
NAT IMMUNOL. 2018; 19(11): 1212-1223. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schranzer, R; Rauscher, A; Haimburger, E; Bredies, K; Reishofer, G; Grabner, G Noise reduction in FLAIR2 images using total generalized variation, Gaussian and Wiener filtering.
Z Med Phys. 2018; 28(4):286-292
Web of Science PubMed FullText FullText_MUG

 

Sumowski, JF; Benedict, R; Enzinger, C; Filippi, M; Geurts, JJ; Hamalainen, P; Hulst, H; Inglese, M; Leavitt, VM; Rocca, MA; Rosti-Otajarvi, EM; Rao, S Cognition in multiple sclerosis: State of the field and priorities for the future.
Neurology. 2018; 90(6):278-288 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger, C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M The effect of disease modifying therapies on CD62L expression in multiple sclerosis.
Mult Scler J Exp Transl Clin. 2018; 4(3):2055217318800810-2055217318800810 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Walleczek, NK; Frommlet, F; Bsteh, G; Eggers, C; Rauschka, H; Koppi, S; Assar, H; Ehling, R; Birkl, C; Salhofer-Polanyi, S; Baumgartner, A; Blechinger, S; Buchinger, D; Sellner, J; Kraus, J; Moser, H; Mayr, M; Guger, M; Rathmaier, S; Raber, B; Liendl, H; Hiller, MS; Parigger, S; Morgenstern, G; Kempf, I; Spiss, HK; Meister, B; Heine, M; Cisar, A; Bachler, H; Khalil, M; Fuchs, S; Enzinger, C; Fazekas, F; Leutmezer, F; Berger, T; Kristoferitsch, W; Aboulenein-Djamshidian, F Month-of-birth-effect in multiple sclerosis in Austria.
Mult Scler. 2018; 1352458518810924-1352458518810924
PubMed FullText FullText_MUG

 

2017

Baker, D; Pryce, G; Visintin, C; Sisay, S; Bondarenko, AI; Vanessa Ho, WS; Jackson, SJ; Williams, TE; Al-Izki, S; Sevastou, I; Okuyama, M; Graier, WF; Stevenson, LA; Tanner, C; Ross, R; Pertwee, RG; Henstridge, CM; Irving, AJ; Schulman, J; Powell, K; Baker, MD; Giovannoni, G; Selwood, DL Big conductance calcium-activated potassium channel openers control spasticity without sedation.
Br J Pharmacol. 2017; 174(16):2662-2681 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Benedict, RHB; DeLuca, J; Enzinger, C; Geurts, JJG; Krupp, LB; Rao, SM Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward.
J Int Neuropsychol Soc. 2017; 23(9-10):832-842
Web of Science PubMed FullText FullText_MUG

 

Bornemann-Cimenti, H; Sivro, N; Toft, F; Halb, L; Sandner-Kiesling, A [Neuraxial anesthesia in patients with multiple sclerosis - a systematic review].
Rev Bras Anestesiol. 2017; 67(4):404-410 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Brownlee, WJ; Hardy, TA; Fazekas, F; Miller, DH Diagnosis of multiple sclerosis: progress and challenges.
Lancet. 2017; 389(10076):1336-1346
Web of Science PubMed FullText FullText_MUG

 

Burgetova, A; Dusek, P; Vaneckova, M; Horakova, D; Langkammer, C; Krasensky, J; Sobisek, L; Matras, P; Masek, M; Seidl, Z Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.
AJNR Am J Neuroradiol. 2017; 38(6):1079-1086 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Damjanovic, D; Valsasina, P; Rocca, MA; Stromillo, ML; Gallo, A; Enzinger, C; Hulst, HE; Rovira, A; Muhlert, N; De Stefano, N; Bisecco, A; Fazekas, F; Arévalo, MJ; Yousry, TA; Filippi, M Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.
AJNR Am J Neuroradiol. 2017; 38(1):18-24 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

de Sitter, A; Steenwijk, MD; Ruet, A; Versteeg, A; Liu, Y; van Schijndel, RA; Pouwels, PJW; Kilsdonk, ID; Cover, KS; van Dijk, BW; Ropele, S; Rocca, MA; Yiannakas, M; Wattjes, MP; Damangir, S; Frisoni, GB; Sastre-Garriga, J; Rovira, A; Enzinger, C; Filippi, M; Frederiksen, J; Ciccarelli, O; Kappos, L; Barkhof, F; Vrenken, H; MAGNIMS study group and for neuGRID Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS study.
Neuroimage. 2017; 163(496):106-114
Web of Science PubMed FullText FullText_MUG

 

Engelborghs, S; Niemantsverdriet, E; Struyfs, H; Blennow, K; Brouns, R; Comabella, M; Dujmovic, I; van der Flier, W; Frölich, L; Galimberti, D; Gnanapavan, S; Hemmer, B; Hoff, E; Hort, J; Iacobaeus, E; Ingelsson, M; Jan de Jong, F; Jonsson, M; Khalil, M; Kuhle, J; Lleó, A; de Mendonça, A; Molinuevo, JL; Nagels, G; Paquet, C; Parnetti, L; Roks, G; Rosa-Neto, P; Scheltens, P; Skårsgard, C; Stomrud, E; Tumani, H; Visser, PJ; Wallin, A; Winblad, B; Zetterberg, H; Duits, F; Teunissen, CE Consensus guidelines for lumbar puncture in patients with neurological diseases.
Alzheimers Dement (Amst). 2017; 8(6):111-126 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Goswami, N; Blaber, AP; Hinghofer-Szalkay, H; Montani, JP Orthostatic Intolerance in Older Persons: Etiology and Countermeasures.
Front Physiol. 2017; 8(52):803-803 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hennes, EM; Baumann, M; Schanda, K; Anlar, B; Bajer-Kornek, B; Blaschek, A; Brantner-Inthaler, S; Diepold, K; Eisenkölbl, A; Gotwald, T; Kuchukhidze, G; Gruber-Sedlmayr, U; Häusler, M; Höftberger, R; Karenfort, M; Klein, A; Koch, J; Kraus, V; Lechner, C; Leiz, S; Leypoldt, F; Mader, S; Marquard, K; Poggenburg, I; Pohl, D; Pritsch, M; Raucherzauner, M; Schimmel, M; Thiels, C; Tibussek, D; Vieker, S; Zeches, C; Berger, T; Reindl, M; Rostásy, K; BIOMARKER Study Group Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
NEUROLOGY. 2017; 89(9): 900-908. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Herrmann, M; Farrell, CL; Pusceddu, I; Fabregat-Cabello, N; Cavalier, E Assessment of vitamin D status - a changing landscape.
Clin Chem Lab Med. 2017; 55(1): 3-26. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kolbinger, F; Loesche, C; Valentin, MA; Jiang, X; Cheng, Y; Jarvis, P; Peters, T; Calonder, C; Bruin, G; Polus, F; Aigner, B; Lee, DM; Bodenlenz, M; Sinner, F; Pieber, TR; Patel, DD β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis.
J Allergy Clin Immunol. 2017; 139(3):923-932 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Robier, C; Amouzadeh-Ghadikolai, O; Bregant, C; Diez, J; Melinz, K; Quehenberger, F; Quasthoff, S The frequency of occurrence of atypical lymphocytes in peripheral blood smears of natalizumab-treated patients with multiple sclerosis.
Int J Lab Hematol. 2017; 39(5):469-474
Web of Science PubMed FullText FullText_MUG

 

Ropele, S; Enzinger, C; Fazekas, F Iron Mapping in Multiple Sclerosis.
Neuroimaging Clin N Am. 2017; 27(2):335-342
Web of Science PubMed FullText FullText_MUG

 

Üçal, M; Haindl, MT; Adzemovic, MZ; Strasser, J; Theisl, L; Zeitelhofer, M; Kraitsy, K; Ropele, S; Schäfer, U; Fazekas, F; Hochmeister, S Widespread cortical demyelination of both hemispheres can be induced by injection of pro-inflammatory cytokines via an implanted catheter in the cortex of MOG-immunized rats.
Exp Neurol. 2017; 294(7):32-44
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen
© Meduni Graz Impressum